The Effect of Metacognition-based, Manualized Intervention on Fear of Cancer Recurrence

  • STATUS
    Recruiting
  • End date
    Dec 31, 2023
  • participants needed
    174
  • sponsor
    The University of Hong Kong
Updated on 27 June 2022

Summary

The primary aim of this study is to assess the effect of ConquerFear, a metacognition-based manualized intervention on fear of cancer recurrence, using the randomized controlled trial approach, among Chinese patients newly diagnosed with curable cancer. This study aims to (1) test the direct effect of ConquerFear intervention on fear of cancer recurrence and on maladaptive metacognition, and (2) to test the indirect effect of ConquerFear intervention on fear of cancer recurrence through its effect on maladaptive metacognition.

Description

A randomized controlled trial will be conducted to test the effect of a metacognition-based manualized intervention on fear of cancer recurrence among Chinese breast, gynecologic and colorectal cancer patients with high levels of fear of cancer recurrence.

The aims are to test:

  1. the direct effect of ConquerFear intervention on fear of cancer recurrence,
  2. the direct effect of ConquerFear intervention on maladaptive metacognition
  3. the indirect effect of ConquerFear intervention on fear of cancer recurrence through its effect on maladaptive metacognition.

Primary hypothesis:

  1. Participants in the ConquerFear intervention will show a greater reduction in fear of cancer recurrence compared to participants in the control group
  2. Participants in the ConquerFear intervention will show a greater reduction in maladaptive metacognition than the control participants
  3. There will be an indirect effect of ConquerFear intervention on fear of cancer recurrence through its effect on maladaptive metacognition.

Details
Condition Fear of Cancer Recurrence
Treatment ConquerFear Intervention, Active control: Basic Cancer Care
Clinical Study IdentifierNCT04568226
SponsorThe University of Hong Kong
Last Modified on27 June 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

Cantonese- or Mandarin-speaking Chinese patients recently diagnosed with non-metastatic breast cancer, gynecologic cancer, or colorectal cancer
had surgery as a primary treatment
have had completed hospital-based adjuvant treatments including radiotherapy and chemotherapy within the past 18 months
with the cut-off scored ≥ 13 on Severity, the subscale of Fear of cancer inventory
are able to read and write Chinese
are over the age of 18 years

Exclusion Criteria

Patients diagnosed with metastatic cancer
Patients who are illiterate
with a current diagnosis of depression or psychosis
currently receiving psychological treatment
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note